Familial Male-limited Precocious Puberty (FMPP) and Testicular Germ Cell Tumors
Authors:
- Cezanne D KooijCKCezanne D Kooij
- Annelies M C Mavinkurve-GroothuisAMAnnelies M C Mavinkurve-Groothuis
- Idske C L Kremer HovingaIHIdske C L Kremer Hovinga
- Leendert H J LooijengaLLLeendert H J Looijenga
- Tuula RinneTRTuula Rinne
- Jacques C GiltayJGJacques C Giltay
- Laetitia M O de KortLKLaetitia M O de Kort
- Aart J KlijnAKAart J Klijn
- Ronald R de KrijgerRKRonald R de Krijger
- Annemarie A Verrijn StuartASAnnemarie A Verrijn Stuart
Open Access
- 8 September 2022
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (11) , 3035-3044
Abstract
Objective The purpose of this study is to report development of a malignant testicular germ cell tumor (GCT) in two young adult males with Familial Male-limited Precocious Puberty (FMPP) due to (LHCGR) pathogenic variants in two families. Secondary, to study the possible relation between FMPP and testicular tumors and to investigate whether FMPP might predispose to development of malignant testicular tumors in adulthood a literature review is conducted. Methods Data on six cases in two families are obtained from the available medical records. In addition, a database search is performed in Cochrane, Pubmed and Embase for studies that report on a possible link between FMPP and testicular tumors. Results The characteristics of six males with FMPP based on activating luteinizing hormone receptor (LHCGR) germline pathogenic variants are described, as well as details of the testicular GCTs. Furthermore, literature review identified four more patients with signs of FMPP and a (precursor of a) testicular GCT in adolescence or adulthood (age 15 to 35 years). Additionally, twelve patients with signs of precocious puberty and, simultaneously, occurrence of a Leydig cell adenoma or Leydig cell hyperplasia are reported. Conclusion There is a strong suggestion that FMPP might increase the risk of development of testicular GCTs in early adulthood compared to the risk in the general population. Therefore, prolonged patient monitoring from mid-pubertal age onwards including instruction for self-examination and periodic testicular ultrasound investigation in patients with a germline LHCGR pathogenic variants might contribute to early detection and thus early treatment of testicular GCT.Keywords
This publication has 37 references indexed in Scilit:
- SRY mutation analysis by next generation (deep) sequencing in a cohort of chromosomal Disorders of Sex Development (DSD) patients with a mosaic karyotypeBMC Medical Genetics, 2012
- Association of polymorphisms in survivin gene with the risk of hepatocellular carcinoma in Chinese han population: a case control studyBMC Medical Genetics, 2012
- Mutation Analysis of the LH Receptor Gene in Leydig Cell Adenoma and Hyperplasia and Functional and Biochemical Studies of Activating Mutations of the LH Receptor GeneThe Journal of Clinical Endocrinology & Metabolism, 2011
- Bicalutamide and Third-Generation Aromatase Inhibitors in TestotoxicosisPediatrics, 2010
- A novel SRY missense mutation affecting nuclear import in a 46,XY female patient with bilateral gonadoblastomaEuropean Journal of Human Genetics, 2009
- Tumor risk in disorders of sex development (DSD)Best Practice & Research Clinical Endocrinology & Metabolism, 2007
- Leydig-Cell Tumors Caused by an Activating Mutation of the Gene Encoding the Luteinizing Hormone ReceptorNew England Journal of Medicine, 1999
- Heterogeneity of Activating Mutations of the Human Luteinizing Hormone Receptor in Male-Limited Precocious PubertyBiochemical and Molecular Medicine, 1996
- Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious pubertyHuman Molecular Genetics, 1993
- A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious pubertyNature, 1993